MIAMI BEACH, FL—Pulmonary embolism (PE), an often-deadly condition that’s best served by a multidisciplinary approach to care, is the perfect target for artificial intelligence (AI), according to ...

HOLLYWOOD, FL—Growing interest in rapid-response teams to treat pulmonary embolism (PE), popularly known as PERTs, is tempered by the absence of firm numbers to support available therapies, ...

The use of echocardiography, which creates two-dimensional images of the heart, can help clinicians better predict outcomes for individuals with pulmonary embolisms, says a Yale author of a new study.

With the availability of new treatment for thromboembolism that can be administered at home, the management of pulmonary embolism is changing. This has implications for both the location and provision ...

Please provide your email address to receive an email when new articles are posted on . Patients with a prior history of pulmonary embolism had worse outcomes after TJA vs. patients without such ...

A pulmonary embolism can be life-threatening and nurses have a huge role to play in improving patient outcomes. This article discusses diagnosis, risk factors and preventive management Pulmonary ...

Patients with acute pulmonary embolism can be selected for home management using the sPESI score or the Hestia criteria, according to results of the HOME-PE trial presented in a Hot Line session today ...

Rapidai Inc. Received U.S. FDA 510(k) clearance for Rapid RV/LV, the latest addition to its pulmonary embolism (PE) solution. Rapid RV/LV uses artificial intelligence to quickly calculate the right ...

A pulmonary embolism occurs when one or more blood clots move from somewhere in your body to the lungs. The clot becomes lodged in a pulmonary (lung) artery and blocks the blood flow. A pulmonary ...

Deep vein thrombosis (DVT) and pulmonary embolism (PE) are a major cause of admissions to hospital. Both have a lifetime incidence of approximately 2-5 per cent, with the incidence of PE being around ...

Imperative Care has completed subject enrolment in the pivotal investigational device exemption (IDE) trial, SYMPHONY-PE, assessing the Symphony thrombectomy system's efficacy and safety in treating ...